Amber P van der Zalm

2PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 17, 2024
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma.

Amber P van der Zalm, Mark P G Dings, Paul Manoukian

|Apr 26, 2022
FOXO transcriptional activity is associated with response to chemoradiation in EAC.

A Creemers, A P van der Zalm, A van de Stolpe

Pageof 1